Correlation Between PLA Levels and Disease Severity in Patients With Sepsis Cardiac Insufficiency

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Sepsis cardiac insufficiency is characterized by high morbidity and mortality. Studies have shown an association between elevated PLA levels in patients with sepsis and clinical outcomes of cardiac dysfunction. This study will explore the correlation between circulating PLA levels and organ dysfunction and disease severity in SIMD patients in the form of a cross-sectional study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 90
Healthy Volunteers: t
View:

• Sepsis cardiac insufficiency group

‣ From April 2024 to December 2026, in the first ICU area of Dongzhimen Hospital, Beijing University of Chinese Medicine, Hospitalized patients in Zone II;

⁃ consistent with the diagnosis of sepsis cardiac insufficiency;

⁃ Age ≥ 50 and ≤ 90 years old;

⁃ SOFA score≥ 2 points;

⁃ Within 24 hours of the diagnosis of cardiac insufficiency in sepsis;

⁃ The patient or his/her family members sign the informed consent form. Healthy subjects

• <!-- -->

‣ Aged ≥ 50 and ≤ 90 years old, permanent residents of Beijing community;

⁃ Good health (blood routine, liver and kidney function, blood lipids, blood coagulation, no obvious abnormalities, no diagnosis cardiac insufficiency, acute coronary syndrome, old myocardial infarction, or cardiomyopathy);

⁃ There is no history of long-term use of drugs that affect platelet function and coagulation function, and those who are willing to cooperate with the test Crowd;

⁃ The subject himself signed the informed consent form.

Locations
Other Locations
China
DongzhimenH,Beijing
RECRUITING
Beijing
Contact Information
Primary
Yao Sheng Xiu
a2w029@bucm.edu.cn
86-15600089226
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 30
Treatments
Sepsis cardiac insufficiency group
Cardiac dysfunction or hemodynamic abnormalities in patients with sepsis, combined with abnormal cardiac ultrasound findings, markers of myocardial injury, and/or markers of cardiac function~1. From April 2024 to December 2026, in the first ICU area of Dongzhimen Hospital, Beijing University of Chinese Medicine,Hospitalized patients in Zone II;~2. consistent with the diagnosis of sepsis cardiac insufficiency;~3. Age ≥ 50 and ≤ 90 years old;~4. SOFA score≥ 2 points;~5. Within 24 hours of the diagnosis of cardiac insufficiency in sepsis;~6. The patient or his/her family members sign the informed consent form.
Healthy subjects
1. Aged ≥ 50 and ≤ 90 years old, permanent residents of Beijing community;~2. Good health (blood routine, liver and kidney function, blood lipids, blood coagulation, no obvious abnormalities, no diagnosis cardiac insufficiency, acute coronary syndrome, old myocardial infarction, or cardiomyopathy);~3. There is no history of long-term use of drugs that affect platelet function and coagulation function, and those who are willing to cooperate with the test Crowd;~4. The subject himself signed the informed consent form.
Related Therapeutic Areas
Sponsors
Leads: Dongzhimen Hospital, Beijing

This content was sourced from clinicaltrials.gov